Skip to Content

Aspira Womens Health Inc AWH

Morningstar Rating
$3.38 −0.05 (1.46%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AWH is trading at a 40% discount.
Price
$3.55
Fair Value
$7.73
Uncertainty
Extreme
1-Star Price
$97.77
5-Star Price
$7.46
Economic Moat
Ynpwp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AWH is a good fit for your portfolio.

Trading Information

Previous Close Price
$3.43
Day Range
$3.313.68
52-Week Range
$2.316.75
Bid/Ask
$3.35 / $3.39
Market Cap
$34.94 Mil
Volume/Avg
7,707 / 31,113

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.90
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1’s high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
85

Valuation

Metric
AWH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
2.90
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AWH
Quick Ratio
1.30
Current Ratio
1.47
Interest Coverage
Quick Ratio
AWH

Profitability

Metric
AWH
Return on Assets (Normalized)
−127.94%
Return on Equity (Normalized)
−497.42%
Return on Invested Capital (Normalized)
−269.94%
Return on Assets
AWH
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncMmmqpbhlstKvdnl$220.9 Bil
DHR
Danaher CorpMbwsqhfmpChnrp$184.0 Bil
IQV
IQVIA Holdings IncXfcxlpnQvkql$46.0 Bil
IDXX
IDEXX Laboratories IncZcrmzvvgTzbzlw$44.8 Bil
A
Agilent Technologies IncMgvxndkqZgrd$43.2 Bil
MTD
Mettler-Toledo International IncQwzcgzcvWmxybq$28.6 Bil
ICLR
Icon PLCFckdkrnfpCvhnzj$27.2 Bil
ILMN
Illumina IncRmthrflFdpfmk$22.0 Bil
WAT
Waters CorpHzlcycszbHvcq$20.4 Bil
LH
Laboratory Corp of America HoldingsXvdrwvcfJnrdrb$18.2 Bil

Sponsor Center